Variables | MMR status | p value | |
---|---|---|---|
p-MMR | d-MMR | ||
Sex | Â | Â | 0.102 |
 male | 516/2031 (25.4%) | 55/2031 (2.7%) |  |
 female | 1375/2031 (67.7%) | 85/2031 (4.2%) |  |
Lauren type | Â | Â | 0.012* |
 Diffuse/mixed | 1201/2031 (59.1%) | 74/2031 (3.6%) |  |
 intestinal | 690/2031 (34%) | 66/2031 (3.2%) |  |
Differentiation | Â | Â | 0.256 |
 poorly | 1264/2031 (62.2%) | 87/2031 (4.3%) |  |
 well-moderately | 627/2031 (30.9%) | 53/2031 (2.6%) |  |
T stage | Â | Â | 0.038 |
 pT3 + T4 | 1193/2031 (58.7%) | 88/2031 (4.3%) |  |
 pT1 + T2 | 698/2031 (34.4%) | 52/2031 (2.6%) |  |
Lymphnode metastasis | Â | Â | 0.246 |
 LNM+ | 1121/2031 (55.2%) | 76/2031 (3.7%) |  |
 LNM- | 770/2031 (37.9%) | 64/2031 (3.2%) |  |
PD-L1 expression | Â | Â | 0.000* |
 PD-L1 - | 1337/2031 (65.8%) | 69/2031 (3.4%) |  |
 PD-L1 > =1% | 554/2031 (27.3%) | 71/2031 (3.5%) |  |